KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $278.0 million.

  • Colgate Palmolive's Change in Accured Expenses rose 10902.26% to $278.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.0 million, marking a year-over-year decrease of 5320.51%. This contributed to the annual value of $516.0 million for FY2024, which is 6699.03% up from last year.
  • According to the latest figures from Q3 2025, Colgate Palmolive's Change in Accured Expenses is $278.0 million, which was up 10902.26% from -$191.0 million recorded in Q2 2025.
  • Colgate Palmolive's Change in Accured Expenses' 5-year high stood at $278.0 million during Q3 2025, with a 5-year trough of -$191.0 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $15.0 million (2023), whereas its average is $39.7 million.
  • In the last 5 years, Colgate Palmolive's Change in Accured Expenses skyrocketed by 78666.67% in 2024 and then crashed by 81250.0% in 2025.
  • Colgate Palmolive's Change in Accured Expenses (Quarter) stood at $121.0 million in 2021, then tumbled by 202.48% to -$124.0 million in 2022, then surged by 213.71% to $141.0 million in 2023, then skyrocketed by 34.04% to $189.0 million in 2024, then surged by 47.09% to $278.0 million in 2025.
  • Its Change in Accured Expenses was $278.0 million in Q3 2025, compared to -$191.0 million in Q2 2025 and -$57.0 million in Q1 2025.